Clear Evidence This Week That Eisai and Biogen's Drug Lecanemab Slows Cognitive Decline in ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'Clear evidence this week that Eisai and Biogen's drug lecanemab slows cognitive decline in early-stage dementia has galvanized efforts among Alzheimer's researchers toward a tantalizing goal - preventing dementia even before symptoms start ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)